Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 4.56 is strong.
PT Enseval Putera Megatrading Tbk has a Altman Z-Score of 4.57, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for PT Enseval Putera Megatrading Tbk's Altman Z-Score or its related term are showing as below:
ISX:EPMT'
s Altman Z-Score Range Over the Past 10 Years
Min: 4.56 Med: 5.66 Max: 6.69
Current: 4.56
During the past 13 years, PT Enseval Putera Megatrading Tbk's highest Altman Z-Score was 6.69. The lowest was 4.56. And the median was 5.66.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:EPMT vs MCK, COR, CAH: Altman Z-Score Comparison
For the Medical Distribution subindustry, PT Enseval Putera Megatrading Tbk's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Enseval Putera Megatrading Tbk Altman Z-Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Enseval Putera Megatrading Tbk's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where PT Enseval Putera Megatrading Tbk's Altman Z-Score falls into.
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
PT Enseval Putera Megatrading Tbk (ISX:EPMT) has a Altman Z-Score of 4.57 as of Aug. 01, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. This is 19% below median its historical median of 5.66. Over the past decade, PT Enseval Putera Megatrading Tbk's Altman Z-Score has ranged from 4.56 to 6.69. According to the industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #25 out of 120 companies in the Medical Distribution industry, placing it in the top 20.8%.
Is PT Enseval Putera Megatrading Tbk's Altman Z-Score too high?
PT Enseval Putera Megatrading Tbk's current Altman Z-Score of 4.57 is 19% below median its 10-year median of 5.66. Over the past 10 years, this metric has ranged from a low of 4.56 to a high of 6.69. The Medical Distribution industry median Altman Z-Score is 2.58. PT Enseval Putera Megatrading Tbk's value of 4.57 is 77.1% above this industry median. Based on the distribution chart, PT Enseval Putera Megatrading Tbk ranks #25 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Enseval Putera Megatrading Tbk has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Enseval Putera Megatrading Tbk's Altman Z-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Enseval Putera Megatrading Tbk ranks #25 out of 120 companies for Altman Z-Score. This places PT Enseval Putera Megatrading Tbk in the top 21% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.58. PT Enseval Putera Megatrading Tbk's value of 4.57 is 77.1% above this benchmark. Historically, PT Enseval Putera Megatrading Tbk's own Altman Z-Score has ranged from 4.56 to 6.69 over the past decade. While the company's 10-year median is 5.66 vs. the industry median of 2.58, PT Enseval Putera Megatrading Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Distribution company?
The median Altman Z-Score among Medical Distribution companies is 2.58, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Enseval Putera Megatrading Tbk's current Altman Z-Score of 4.57 is 77.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on PT Enseval Putera Megatrading Tbk and its competitors. For the Medical Distribution industry, the median Altman Z-Score is 2.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Enseval Putera Megatrading Tbk's current Altman Z-Score is 4.57, which is 19% below median its own 10-year median of 5.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Enseval Putera Megatrading Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk (ISX:EPMT) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp2,689.14, compared to a current price of Rp2,360.00 — trading 12.2% below its estimated fair value. The current Altman Z-Score is 4.57, which is 19% below median its 10-year median of 5.66 and 77.1% above the Medical Distribution industry median of 2.58. PT Enseval Putera Megatrading Tbk's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For PT Enseval Putera Megatrading Tbk (ISX:EPMT), the current Altman Z-Score is 4.57 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Enseval Putera Megatrading Tbk (ISX:EPMT) Overvalued in 2026?
Based on GuruFocus' analysis, PT Enseval Putera Megatrading Tbk stock appears to be undervalued.
The current stock price of Rp2,360.00 is trading 12.2% below its estimated GF Value™ of Rp2,689.14.
GuruFocus considers PT Enseval Putera Megatrading Tbk to be Modestly Undervalued.
Key valuation signals for ISX:EPMT:
Altman Z-Score: 4.57 (19% below median its 10-year median of 5.66)
GF Value™: Rp2,689.14 vs. price of Rp2,360.00 (12.2% below fair value)
Industry Position: 77.1% above the Medical Distribution median (#25 of 120)
No single metric tells the full story. See the ISX:EPMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Enseval Putera Megatrading Tbk is a general distributor dealing in pharmaceutical products, consumer products, and medical devices. The company also acts as an agent and distributor of consumer goods, prescription medicines, non-prescription medicines, raw materials for the pharmaceutical, medical equipment, including marketing activities, veterinary medicines, cosmetics, and other industries. The company's business segments are Pharmaceuticals which generates maximum revenue; Consumer products, and Others.
89GF Score
Get the complete analysis for ISX:EPMT
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:EPMT has been successfully added to your 
